Evogene Ltd. (EVGN)
NASDAQ: EVGN · IEX Real-Time Price · USD
0.600
+0.005 (0.86%)
At close: Jul 19, 2024, 4:00 PM
0.670
+0.070 (11.69%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Evogene Market Cap

Evogene has a market cap or net worth of $30.34 million as of July 22, 2024. Its market cap has decreased by -33.75% in one year.

Market Cap
30.34M
Enterprise Value
15.07M
1-Year Change
-33.75%
Ranking
Category
Stock Price
$0.60

Market Cap Chart

Since December 31, 2012, Evogene's market cap has decreased from $226.30M to $30.34M, a decrease of -86.59%. That is a compound annual growth rate of -15.96%.

History

DateMarket Cap% Change
Jul 19, 202430.40M-28.47%
Dec 29, 202342.50M47.06%
Dec 30, 202228.90M-57.19%
Dec 31, 202167.50M-54.61%
Dec 31, 2020148.70M280.31%
Dec 31, 201939.10M-23.33%
Dec 31, 201851.00M-34.78%
Dec 29, 201778.20M-39.66%
Dec 30, 2016129.60M-36.50%
Dec 31, 2015204.10M-10.99%
Dec 31, 2014229.30M-51.52%
Dec 31, 2013473.00M109.01%
Dec 31, 2012226.30M-
View and export this data all the way back to 2012. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Equillium 30.67M
NKGen Biotech 30.67M
MiNK Therapeutics 30.56M
CareCloud 30.51M
Spectral AI 30.42M
Lipocine 30.22M
Pluri 29.89M
Daré Bioscience 29.82M
Market Cap Rankings